BSI PD CEN/TR 17612:2021
$167.15
Algae and algae products. Specifications for pharmaceutical sector applications
Published By | Publication Date | Number of Pages |
BSI | 2021 | 42 |
This document gives an overview of recommendations on product specifications, and other relevant information, for algae and algae products for pharmaceutical applications.
This document does not apply to food and feed applications.
This document does not provide instructions on handling of technical requirements in existing legislations.
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | undefined |
8 | 1 Scope 2 Normative references 3 Terms and definitions |
10 | 4 Product characteristics 4.1 Product purity 4.1.1 General |
11 | 4.1.2 Purity of microalgae and cyanobacteria 4.1.3 Purity of macroalgae |
12 | 4.1.4 Purity of algae derivatives or extracts |
13 | 4.1.5 Methods of analysis |
14 | 4.2 Contamination 4.2.1 General 4.2.2 Physical, biological and chemical contaminants 4.2.3 Microbiological quality of algae and algae biomass |
15 | 4.2.4 Contaminants in algae and algal pharmaceutical ingredients 4.2.4.1 General 4.2.4.2 Heavy metals |
16 | 4.2.4.3 Dioxins and related xenobiotes 4.2.4.4 PAHs 4.2.4.5 Uranium 4.2.4.6 Iodine |
17 | 4.2.4.7 Pesticide residues 4.2.4.8 Residual solvents |
18 | 4.3 Other product characteristics 4.3.1 Identification 4.3.2 Particle size 4.3.3 Foreign matter |
19 | 4.3.4 Total ash, insoluble ash 4.3.5 Extractable matter 4.3.6 Swelling index 4.3.7 Bitterness value 4.3.8 Loss on drying 4.3.9 Water (for herbal drugs with high essential oil content) |
20 | 4.3.10 Assay 5 Storage 6 Labelling |
21 | 7 Product information documents 7.1 General 7.2 Material Safety Data Sheet 7.3 Other relevant product information 7.3.1 Origin 7.3.2 Strain origin 7.3.3 Product origin 7.4 Protected species |
22 | 7.5 Algae extracts 8 Sustainable development 8.1 General 8.2 United Nations sustainable development goals 8.3 Macroalgae biomass can be supplied by harvesting of wild stocks or aquaculture. |
23 | 8.4 Sustainable development of microalgae production 9 Traceability 9.1 General |
24 | 9.2 Chain of Custody 10 Algae in EP and USP General Monographs |
25 | Annex A (informative)Regulatory framework A.1 Regulatory framework in UE A.2 Regulatory framework outside UE |
26 | Annex B (informative)Raw Material Specifications examples B.1 Example of cyanobacterium biomass Specifications (Spirulina monograph) |
27 | B.2 Example of seaweed biomass Specifications (Fucus monograph) |
29 | Annex C (informative)Technical Data Sheets (TDS) examples |
32 | Annex D (informative)Origin of algae products D.1 Origin of algae strains D.2 Origin of algae products |
34 | D.3 Origin Statement |
35 | Annex E (informative)Algae extracts E.1 Algae extracts for pharmaceutical purposes E.2 Solvent properties |
36 | E.3 Solvent extraction vs CO2-Extraction E.4 Algae biomass CO2-Extraction |
38 | Annex F (informative)Purity identification methods and gap analysis algae |